American Well Corporation ( (AMWL) ) has released its Q2 earnings. Here is a breakdown of the information American Well Corporation presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
American Well Corporation, known as Amwell, is a prominent provider of a comprehensive SaaS-based healthcare platform, focusing on delivering technology-enabled healthcare solutions to enhance patient access and care delivery across the healthcare continuum.
In its latest earnings report for the second quarter of 2025, Amwell highlighted significant strategic advancements, including the addition of Florida Blue to its strategic clients and an extension award from the US Defense Health Agency. These developments underscore the growing recognition and validation of Amwell’s platform in the healthcare sector.
Financially, Amwell reported a total revenue of $70.9 million, with subscription revenue contributing $40.4 million and Amwell Medical Group visit revenue accounting for $22.8 million. The company achieved a gross margin of 56.1%, although it recorded a net loss of $19.5 million. Notably, the adjusted EBITDA improved to a loss of $4.7 million from $12.2 million in the previous quarter, reflecting progress in revenue quality and cost alignment.
Looking ahead, Amwell has revised its 2025 revenue guidance to a range of $245 million to $250 million, reflecting the impact of its strategic divestiture. The company remains committed to achieving positive cash flow from operations by 2026, indicating a focused approach towards financial stability and growth in the coming years.